S

Spur Therapeutics

Biotechnology Research · United Kingdom · 500 employees

12 Decision makers
+1 New (6 months)
500 Employees
2015 Founded

Organizational Chart of Spur Therapeutics

Roles identified within Spur Therapeutics's leadership team, from public professional data, updated 25 Oct 2026.

Department

Spur Therapeutics's Full Organizational Chart

Loading…

Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Spur Therapeutics by function

General management

Finance

Other functions

See all Spur Therapeutics contacts on Zeliq

Decision makers at Spur Therapeutics

12 identified 3 C-Level 2 VP 7 Directors +1 new (6 months)
See them on Zeliq →

Departments actively hiring 1 department

Operations

These departments at Spur Therapeutics are actively recruiting: a strong signal to time your outreach.

Funding and news at Spur Therapeutics

Funding

Last round Seed · $50M
Total funding $341M (10 rounds)
Corporate Round N/A Mar 2015
Series A $38M Dec 2015
Series A $1M Jun 2016
Grant $530K Jan 2018
Series B $116M Jun 2018
Grant N/A May 2019
Series C $40M Dec 2019
Series C $80M Jun 2020
Post-IPO Debt $15M Nov 2023
Funding Round $50M Jun 2024

Latest news at Spur Therapeutics

  1. Appointment

    New Chief Operating Officer appointed — General management

Get these new hires' email and phone →

Team Structure headcount by department

Hiring Operations
8
General Management
6
Finance
5
Medical
5
Other
3
Research
3
Project Management
2
Technical
2

How to prospect Spur Therapeutics's departments

Operations

The company's largest department (8 people), currently in an active hiring phase. Operations leaders live in the concrete: a pilot scoped on one process will convince more than a demo.

General Management

The company's second-largest department (6 people). A good executive approach often starts lower in the organisation: build an internal champion before going top-down.

Finance

5 people work in this department. Build your pitch around ROI, payback period and risk reduction: the language this department speaks.

Medical

A team of 5 people. Time with patients is the priority: position your solution as a way to give hours back to care.

Other

This department counts 3 people. A cross-functional team where use cases vary: qualify the actual roles before tailoring your pitch.

Research

3 people work in this department. Long cycles and rigorous methods: respect their pace and bring evidence, not hype.

Try the Zeliq email finder demo →

FAQ Spur Therapeutics

Who runs Spur Therapeutics?

The highest-ranking leadership role identified at Spur Therapeutics is “CFO”, based on public data updated 25 Oct 2026.

How many decision makers does Spur Therapeutics have?

12 decision makers identified, including 3 at executive level.

How do I contact a decision maker at Spur Therapeutics?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Spur Therapeutics?

Operations, based on published job offers as of 25 Oct 2026.

Companies similar to Spur Therapeutics

More companies to explore

Biotechnology Research · United Kingdom

All Biotechnology Research companies in United Kingdom →

About Spur Therapeutics

Spur Therapeutics is a business specialised in Biotechnology Research, operating from United Kingdom. The company was founded in 2015 and has a workforce of roughly 500 people. Within the wider Professional Services sector, Spur Therapeutics focuses on the Biotechnology Research segment. Spur Therapeutics sells primarily to other businesses (B2B) rather than to end consumers. Spur Therapeutics has raised funding across 10 rounds totalling $341M. Sales teams can rely on this profile to qualify Spur Therapeutics, spot business signals, and connect with verified decision makers.

Activity & Market

Spur Therapeutics operates in the Biotechnology Research segment, part of the broader Professional Services sector. As a B2B company, Spur Therapeutics primarily serves business clients and professional organisations. The company is categorised as “Privately held”.